Pharmaceutical International Lawyers Seminar (PILLS)

Presenting on

• 2008 Regulatory update including issues concerning MR and decentralized procedures and paediatric rewards
• The EU Pharma Sector Inquiry: What next?
• Parallel Trade and the ECJ decision in the GSK case
• Promotion and compliance issues including changes required by the new EFPIA and ABPI Code and the implications of parallel self regulatory and statutory enforcement regimes

RSVP